February 23, 2026 · Form 4 insider transaction
Snyder Mark Howard sold 3,782 shares of Halozyme Therapeutics, Inc. at $70.64 per share, a transaction worth $267.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported disposition of 3,782 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.